William W. Ericson, Director, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 11,723 shares at $18.00 ($211K) on 2015-03-17, disclosed to the SEC on 2015-03-19.
Scheduled sale ($211k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 4,523 | $81K | 38.5% |
| 2 | $18.04 | 7,200 | $130K | 61.5% |
| Total | $18.02 avg | 11,723 | $211K | 100% |
| Filing → |
| ADMS | BUY | 2016-09-16 | $2.1M | — | Filing → |
| ADMS | BUY | 2016-09-14 | $2.6M | — | Filing → |
| ADMS | BUY | 2016-09-09 | $1.9M | — | Filing → |